Transcatheter interventions for severe acute mitral regurgitation following acute myocardial infarction are reviewed as a less invasive alternative to surgery, which carries high morbidity and mortality.
Does transcatheter edge-to-edge repair improve clinical outcomes in patients developing severe mitral regurgitation early after an acute myocardial infarction?
Transcatheter edge-to-edge repair represents a promising, less invasive alternative to surgery for high-risk patients developing severe mitral regurgitation early after an acute myocardial infarction.
Acute mitral regurgitation (MR) may develop in the setting of an acute myocardial infarction (AMI) because of papillary muscle dysfunction or rupture. Severe acute MR in this scenario is a life-threatening complication associated with hemodynamic instability and pulmonary edema, and has been linked to a worse prognosis even after reperfusion. Patients treated solely with medical therapy have the highest mortality rates. Surgery has been the only treatment strategy until recently, but the results of the technique are hindered by high rates of morbidity and mortality. Therefore, the development of less invasive interventions for correcting MR would be ideal. We aimed to review the current role of transcatheter interventions in this clinical setting.
Estévez‐Loureiro et al. (Fri,) conducted a review in Severe acute mitral regurgitation early after an acute myocardial infarction. Transcatheter interventions (percutaneous mitral valve repair) vs. Surgery or medical therapy (historical context) was evaluated. Transcatheter interventions for severe acute mitral regurgitation following acute myocardial infarction are reviewed as a less invasive alternative to surgery, which carries high morbidity and mortality.